Replies to post #146662 on Cytodyn Inc (CYDY)

[PNW_Ironman]

Thanks Latane. I did hear that part. I guess I have to see the approval to believe it. GLTU

[SF Anony]

Really, the discussion starting from about the 20:00 mark is very illuminating with regard to Leronlimab!

[Learning53]

Latane,

I thought this interview was a "good find" especially the portion you noted where Janet Woodcock COULD be referring to Leronlimab/Vyrologix's CD12 Trial.

Now, assuming she maintains this "course" and is referring to Leronlimab "the rubber hits the road."

Either approval at some level or no approval. Of course we all hope and pray for the first option, but must consider alternatives if the second option wins out.

For Consideration: In the event the FDA approves and makes Leronlimab available - GREAT!

*******THE IMPORTANT PART BELOW

If it doesn't or throws more arcane and/or dubious roadblocks (dog studies, different dosage trials, wolverine recovery from Covid re Leronlimab, DUH, Etc.) then it's obvious which way things are going.

In which case I would suggest that Cytodyn, Inc. will not be allowed to achieve a "toehold in the USA."

The Salient point here is "in the USA."

We may have to consider alternatives other than,
"in the USA." I'd be surprised if there weren't other countries that would LOVE to have a pharmaceutical powerhouse...Cytocyn, Inc.

This is not my preference, but an open mind and perhaps some preliminary "groundwork" might be wise. In the event we are stymied here,
the veiled threat might be sufficient, but if not...while it wouldn't be preferable or especially easy, it is a viable option. Also I suspect some countries might be inclined to offer various inducements making the changeover "much more interesting."